fda

AMA Update 135: The latest on FDA authorization for a second booster with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews COVID-19 trending topics and news related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the FDA’s authorization of a second booster shot, as well as changes in COVID treatments and therapies. Additionally, uninsured patients may have to pay high prices out-of-pocket for COVID tests and vaccinations due to lack of federal funding and stalled budget approval.

Read More

AMA Update 127: The FDA on Molnupiravir and COVID-19: What physicians need to know, Part III

In part three of this three-part series, Aimee Hodowanec, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what physicians need to know about Molnupiravir as treatment for COVID-19.

Read More

AMA Update 126: Andrea Garcia, JD, MPH, discusses the latest on vaccines for children 5 and younger

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the FDA’s pivot to wait for more data on vaccines for kids under 5, and what new data from the CDC tells us about booster shots.

Read More

AMA Update 124: The FDA on Paxlovid and COVID-19: What physicians need to know, Part II

In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.

Read More

AMA Update 125: Sandra Fryhofer, MD, on what new FDA licensing & authorization requests mean for patients

AMA CXO Todd Unger dives into new developments from ACIP’s emergency meeting on Feb. 4 with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.

Read More

AMA Update 123: The FDA on Monoclonal Antibody Therapeutics: What physicians need to know, Part I

AMA president Gerald Harmon, MD, welcomes experts from the U.S. Food and Drug Administration (FDA) to discuss what prescribers need to know about COVID-19 therapeutic drugs, Paxlovid and Molnupiravir. Alternative treatment options for high-risk outpatients with mild-moderate COVID-19 are also discussed.

Guest: John Farley, MD, MPH, director, Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA

Read More

AMA Update 121: Gerald Harmon, MD, on what physicians need to know about COVID-19 therapeutics

AMA CXO Todd Unger is joined by the AMA’s president, Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., who shares new information and big takeaways about therapeutics for COVID-19 after his recent conversation with three physician leaders from the FDA.

Read More

AMA Update 97: Andrea Garcia, JD, MPH, discusses recent EUA for Pfizer’s COVID vaccine for 5-11 year olds

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the FDA’s authorization of Pfizer-BioNTech’s coronavirus vaccine for emergency use in children 5 to 11, vaccine mandates in schools, and the AMA’s support of the Biden Administration’s plan to address the nation’s overdose epidemic.

Read More

AMA Update 93: Andrea Garcia, JD, MPH, discusses boosters and pending authorizations

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering booster shots (including FDA and CDC recommendations), COVID case spikes related to dropping temperatures, and a reminder to get your annual flu shot.

Read More

AMA Update 89: Andrea Garcia, JD, MPH, discusses trends and urgent call for pregnant people to get vaccinated

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering movement on FDA’s J&J and Moderna booster EUA consideration, New York’s vaccine mandate, and Merck’s antiviral COVID-19 treatment pill.

Read More